The Case for Reforming Drug Naming: Should Brand Name Trademark Protections Expire upon Generic Entry?
expert_opinion · Level V
Where this comes from
- Record sourced from PubMed, PMID 26859662.
- Also identified by DOI 10.1371/journal.pmed.1001955 and PMC identifier 4747525.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Ameet Sarpatwari and Aaron Kesselheim explore whether stripping branded drugs of trademark protection would improve the efficiency and fairness of health care.
Medical subject headings
- Drug Costs
- Drug Industry
- Drugs, Generic
- Economic Competition
- Patents as Topic